Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)
Year: 2022
Type: article
Study design: Observational Study
Institutions: Yale University, Harvard University, Massachusetts General Hospital, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Winship Cancer Institute, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University, Yale Cancer Center, Smilow Cancer Hospital
Language: English
Subfield: General Health Professions
Field: Health Professions
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4302282054
